FindTrial
Sign In

Severe Reluctant COVID-19 Patients Responding to Convalescent Plasma; A case series

Severe Reluctant COVID-19 Patients Responding to Convalescent Plasma; A case series

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000033323
Enrollment
Unknown
Registered
2020-05-28
Start date
2020-05-11
Completion date
Unknown
Last updated
2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:convalescent plasma of COVID

Sponsors

none
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 50 Years

Inclusion criteria

Inclusion criteria: COVID with convalescent plasma treatment

Exclusion criteria

Exclusion criteria: Non-covid patient

Design outcomes

Primary

MeasureTime frame
Rate of cure;—

Countries

Iraq

Contacts

Public ContactFahmi Hussein Kakamad

University of Sulaimani, Sulaimani, Iraq

Rawizh.mohammed94@gmail.com+96 477 17267454

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026